- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Nanomaterials
Volume 2013 (2013), Article ID 329139, 15 pages
Emerging Stem Cell Controls: Nanomaterials and Plasma Effects
1CSIRO Materials Science and Engineering, P.O. Box 218, Lindfield, NSW 2070, Australia
2Complex Systems, School of Physics, The University of Sydney, NSW 2006, Australia
3CSIRO Materials Science and Engineering, Private Bag 33, Clayton, VIC 3169, Australia
4The Australian Regenerative Medicine Institute, Monash University, VIC 3168, Australia
Received 9 September 2013; Accepted 9 October 2013
Academic Editor: Krasimir Vasilev
Copyright © 2013 F. F. Borghi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Stem cells (SC) are among the most promising cell sources for tissue engineering due to their ability to self-renew and differentiate, properties that underpin their clinical application in tissue regeneration. As such, control of SC fate is one of the most crucial issues that needs to be fully understood to realise their tremendous potential in regenerative biology. The use of functionalized nanostructured materials (NM) to control the microscale regulation of SC has offered a number of new features and opportunities for regulating SC. However, fabricating and modifying such NM to induce specific SC response still represent a significant scientific and technological challenge. Due to their versatility, plasmas are particularly attractive for the manufacturing and modification of tailored nanostructured surfaces for stem cell control. In this review, we briefly describe the biological role of SC and the mechanisms by which they are controlled and then highlight the benefits of using a range of nanomaterials to control the fate of SC. We then discuss how plasma nanoscience research can help produce/functionalise these NMs for more effective and specific interaction with SCs. The review concludes with a perspective on the advantages and challenges of research at the intersection between plasma physics, materials science, nanoscience, and SC biology.
Controlling the fate of stem cells (SC) is one of the most crucial issues in regenerative biology and medicine. This versatile type of cell, with promising applications due to their ability to renew their own population and become other types of cells (Figure 1(c)), constitutes the fundamental element of cell therapy. The approach depends upon isolation of SC cells from a tissue as is the case for adult or somatic SC or undifferentiated SC from a culture of pluripotent SC then culture in vitro to generate differentiated mature functional cells for use in regeneration of aged, injured, and diseased tissues. However, cell therapy presents challenges that goes beyond the usual tissue engineering—which combine high-performance materials and signaling factors with living cells to restore tissue functions. It involves cells which, when stimulated by specific growth/differentiation factors (e.g., soluble proteins, insoluble attached proteins, and extracellular matrix (ECM) molecules), give rise to a range of heterogeneous cell types (Figure 1(c)). The success of this approach relies on knowing which of these factors affects SC fate and how this interaction occurs. This is a very difficult task and also depends on how and when the factors are delivered, that is, affected by the growth factor presentation (conformation) and time dependent. Studies also show that it is not only the chemical factors but also the physical interaction between the biomaterials and SC that influence the behavior of cells in culture [1, 2] since it directs the forces exerted by cells on the ECM and are believed to trigger gene activation and suppression [3–6].
This suggests the important role of controlling the environmental material properties (density, stiffness, and architecture) as well as regarding how exactly the growth/differentiation factors are presented and delivered (Figure 2). For this task, biomaterials are being developed to contain and deliver combinations of factors in a controllable way. Gels that mimic the ECM, functionalized polymers, inert metals/alloys, calcium phosphates, nanoparticles, nanofeatured surfaces, and several others are just some examples of functional materials that are currently used to study and control SC fate [1, 7–13]. Although there has been a considerable advance in the area of gels and scaffolds, here we focus on nanomaterials (nanoparticles, nanofibers, and nanostructured surfaces) that can influence selection, proliferation, and differentiation of SC.
To achieve a greater degree of control, reproducibility, scalability, and synthetic materials have gained a significant advantage over naturally occurring materials . In order to precisely design nanomaterials’ architecture, its mechanical properties and binding sites for the proper presentation of ligands, techniques to produce and functionalize these materials are required. As an attractive alternative to widely used lithography and chemistry processes, we discuss some of the new advances in self-assembled plasma-made nanomaterials . Furthermore, the plasma environment can be used to produce building blocks for nanoscale assembly and reactive free radicals for surface modification and in addition can be used for controlled synthesis and processing of self-organized nanomaterials .
This review will briefly describe in Section 2 the biological role of SC and some of the known mechanisms by which they can be controlled. Section 3 will then highlight the benefits of using a range of nanomaterials to control the fate of SCs. Within Section 4, we discuss how plasma nanoscience has the potential to produce or functionalize these NMs to improve their interaction with SCs. The review will conclude with a perspective on the advantages and challenges of research at the intersection between cell biology, plasma science, materials science, nanoscience, and engineering.
2. The Biological Role of Stem Cells
2.1. Basic Information
Stem cells (SC) are present in mammals from the beginning of their life until their death. They form the first cell aggregates, during embryogenesis, and are able to self-renew their own population and, in order to form an adult animal, can differentiate into virtually any cell type; moreover, within the adult mammal tissue, specific adult SC are also responsible for regenerating mature injured tissues [1, 7–9]. Due to these two defining properties, namely, self-renewability and specific differentiation, SC play a pivotal role in cell therapy for treating/restoring damaged tissues by direct replacement of diseased cells [1, 8, 9, 17].
Stem cells can be divided into two broad categories: pluripotent (embryonic SC (ESC) or induced SC (iPSC)) and adult SC. Each of these different SC types is derived or obtained in different ways [7, 9] (Figures 1(a) and 1(b)). For example, ESC are derived from cells that are removed from the inner cell mass of the blastocyst (or embryoblast); iPSC are a reprogrammed adult cell (from any tissue cell back to pluripotent stem cells) [21, 22]; and the adult SC are found in adult tissues within specific anatomical locations and niches. Adult SCs are found in many tissues and organs such as the bone marrow, gastrointestinal tract, skin, and within the central nervous system where their physiological role is to provide an ongoing supply of mature cells or to facilitate tissue repair [1, 7–9, 23] (Figure 1(b)). Although adult SCs' ability to proliferate and differentiate decreases with the age of the donor and also with time spent in cell culture [24, 25], the use of this approach in cell therapy still remains of great importance as for some tissues it is relatively easy to isolate and manipulate their resident SCs. For example, hematopoietic stem cells are readily isolated from bone marrow or blood and are routinely used for transplantation .
Since 1981, when mouse ESC (mESC) were first isolated by Evans and Kaufman , the use of these cells in regenerative medicine has been the subject of great interest , especially in tissue engineering because of the major limitations of artificial implants . The use of ESC as a cellular model also helps us to understand early developmental events at the molecular and cellular level and potentially models of disease progression and epigenetic regulation of cellular fate [28, 29]. This review will focus on, but is not limited to, SC fate control by use of synthetic nanomaterials, combined or not with the defined growth factors (rather than isolating SC or growth factors themselves). For a discussion of the isolation of SC from different adult tissues [30–32] and the generation of pluripotent cells from multipotent ones through reprogramming, we refer the interested reader to a number of other reviews [21, 22, 33, 34].
2.2. Controlling the Fate of Stem Cells
Growth factors, which for the remainder of this paper will include hormones, proteins, and cytokines, have been shown in numerous works to improve the control over either adult or pluripotent SC. The appropriate use of biochemical signals directly added into the culture medium can maintain or differentiate SC [35–38]. Retinoic acid (RA), activin-A, TGF-beta, and insulin-like growth factor 1 (IGF-1) are seen as being responsible for promoting differentiation of murine ESC (mESC) into lung epithelial progenitor cells and pancreatic endocrine cells (alpha, beta, gamma, and delta) [39, 40]. In addition to the great importance to choose which growth factor to use for SC control, the cellular niche—the specific tissue site responsible for regulation of SC fate in the body [9, 41, 42] (Figure 1(b))—helps us to understand the role of the growth factor availability and presentation time as well as the need for a material support for insoluble transmembrane receptor ligands, as well as its specific presentation to the cells. The material selection can be based on the desire to maintain an undifferentiated SC in a culture for a long time or to directly control cell differentiation [1, 9].
For proper application in tissue engineering or adult SC-based therapy, it is desirable to choose/manufacture a biomaterial that closely mimics the “robust spatial and temporal microenvironment of biophysical and biochemical signals” (such as chemokines, cytokines, and growth factors, membrane ligands, and ECM molecules) [7, 26]. Ideally, this microenvironment is an artificial version of the stem cell niche, promoting SC self-renewal or specific differentiation without loss of the key SC attributes [7, 41–45]. Therefore, to control SC behavior and achieve homogeneous and efficient cell differentiation, it is crucial to understand the effects of the identity, presentation, and density of the differentiation factors (e.g., ligands and signals), as well as the material micro- and nanoarchitecture and mechanical properties, which will be described in the next section [3, 9, 11].
The hydrogel is a well-established culture media that has been used for decades to mimic the microenvironment of stem cells in the human body [2, 8, 46–48]. This is due to its high water content, elasticity, biocompatibility, and the ability of nutrients and growth factors to diffuse through it [46–49]. Hydrogels, either natural or synthetic, closely resemble the consistency of the native body tissue by adjusting the hydrogels’ crosslinks [8, 50]. Thus they provide efficient adhesion sites for cells and biological signals and also guidance for cell orientation and proliferation .
These materials can be used instead of feeder-cell layers for supporting hESC culture and maintenance and were first reported by Xu et al. [51–53] using natural hydrogels, with proven ability to differentiate hESCs . Collagen is an example of a natural hydrogel which is capable of cell encapsulation , support of ESC-derived endothelial cells,  and, in high concentrations, inhibit the embryonic body (EB) apoptosis and enhance its differentiation . Moreover, collagen in association with fibronectin or laminin was able to differentiate SC into endothelial and cardiomyocyte cells, respectively . Furthermore, denaturated collagen becomes porous gelatin, and is also biocompatible and extensively used [57, 58]. Other important natural materials hyaluronic acid and alginate, are both able to encapsulate SC and keep them undifferentiated  and also differentiate SC into cardiac  and hepatic lineage  (Figure 1(c)). Likewise, the commercial Matrigel, comprising multiple natural ECM components, has the ability to direct SC into endothelial cells  and enhanced neovascular formation .
2.3. Present-Day Challenges
The use of natural materials, however, presents some limitations, like batch-to-batch variations, weak mechanical properties, and manufacturing difficulties . Synthetic hydrogels, however, are not usually subject to these limitations and instead offer relatively easy control over biochemical properties and represent risk-free media [7–9, 65, 66]. The most commonly used synthetic biomaterials include polyethylene glycol (PEG), polyvinyl alcohol (PVA), polylactic acid (PLA), and poly(L)lactic acid (PLLA), and polylactic-co-glycolic acid (PLGA), which are microfabricated to be active, degradable, porous, and/or stiff enough to induce SC differentiation both in vitro and in vivo [1, 8, 9]. The first biomaterial listed, PEG, is a polymer composed of nanofibers and is capable of cell encapsulation and differentiation in numerous tissues (e.g., bone tissue [67, 68]). Also being able to maintain a neural SC culture, PLA can be produced with aligned fibers and induce aligned neural cells . The PLGA usually helps differentiating neural SC into neural cells . Moreover, when mixed with PLLA, it also promotes differentiation of ESCs into numerous cell lineages [70–72].
All these results highlight some important factors about the medium architecture and applied forces, present in the natural cell niche, that mechanically control SC fate [2, 73]. Some limitations for the use of hydrogels in the mechanical control of SC fate, however, include an inability to be synthesised at a stiffness that mimics higher mechanical strength tissues such as bone, cartilage, and ligaments . Moreover, although other studies show that hydrogels provide a 3D structure to support cells, this is not always in the right spatial dimension (e.g., nanoscale), as that conferred by nanofibrillar proteins secreted by cells (e.g., collagen) present in cellular niche [9, 69, 74].
Although the successful application of synthetic hydrogels modified with numerous growth factors (GF) to mimic the SC niche and control the SC fate has been demonstrated, the strict control of its chemical functionalization, degradation rates, ligand presentation, and mechanical properties still remain challenging. The strategies adopted nowadays involve the use of nanomaterials [75, 76]. For example, some growth factors can be adsorbed on nanoparticle surfaces and then controllably released in the culture medium. Nanomaterials can also be added to hydrogels in order to control stiffness. Micro- and nanoscale patterning is now capable of building materials with specific topographies in order to control the cell focal interaction in different scales and shapes as well as providing spots for the attachment of localized ligands and preventing diffusion . New technologies also provide better control over the surface chemistry of biomaterials. For example, functionalization with chemical radicals allows the attachment of biological factors or may lead to hydrophilic properties depending on the specific applications.
3. Materials Science Approaches for Stem Cell Control
3.1. Brief Overview and Critical Factors
Substantial research efforts in micro- and nanoscale science and technology are aimed at controlling material topography, surface biochemistry, and mechanical properties, in order to mimic and understand the natural cellular environment. In this way, many techniques (e.g., chemical vapor deposition, lithography, and sputtering) have achieved high fabrication resolutions which made it possible to study the effects of material properties on cell-material interactions [78–81]. These techniques may be used to fabricate nanomaterials, such as nanoparticles, nanodots, nanostructured surfaces, and nanoarchitectured scaffolds composed of nanofibers which can directly affect the cells’ focal attachment and apply forces that change the cell shape and alignment—important factors in controlled cell differentiation [2, 73]. Furthermore, some of these techniques are used to chemically modify the surface with reactive radicals [82, 83], control degradation rates, hydrophilicity , and ensure proper presentation of the growth factors, either soluble or attached, thereby directly influencing SC behavior [7–9, 85].
As extensively reported, the ECM plays a significant role in controlling cellular behavior by different factors (forces, topography, growth factors, and ligands) at different levels—from macro- to nanoscales [1, 7, 9–11, 86]. Here we emphasize that materials science approaches hold a major potential for the recreation of diverse cellular environments, which can control these factors in order to better mimic and understand the natural physicochemical ECM features, any relevant spatial, and temporal scales [7, 8, 10]. The most advanced approach is to reduce the complex in vivo system to a controllable simplified system where the desirable factors (e.g., density, porosity, surface energy, topography, chemical radicals, surface ligands, and soluble factors) are combined with the custom designed nanostructures, surfaces, or scaffolds . This approach is very promising to increase our understanding of the most relevant factors for SC control .
In the following, we will discuss engineered biomaterials with nanofeatures, either functionalized or functionalized with the specific growth factors. This approach helps to maintain SCs “stemness,” which is essential for stem cell therapy or, alternatively, to differentiate the SCs, which is crucial for tissue engineering. Nanomaterials will be discussed in order of increasing dimensionality (from 0D to 3D).
3.2. Zero- and One-Dimensional Nanomaterials
Having at least two dimensions in the nanoscale, 0D and 1D materials have huge surface/volume ratios which enable properties that are different compared to film/bulk materials. These properties are mainly guided by the materials’ composition, size, and shape, crystallinity, and how they emerge as a surface property [76, 87–89]. Depending on the media, some characteristics, such as the surface charge, hydrophobicity, particle aggregation, and dissolution, are of great importance for biological applications. Moreover, these properties regulate the interaction of nanomaterials with proteins dispersed in the media [75, 76, 90, 91] and with cells (e.g., binding receptors, blocking pores, and membrane rupture) [92–94].
Nanoparticles, nanodots, nanowires, carbon nanotubes (CNT), graphene flakes, and many other zero- and one-dimensioned materials have found numerous applications in biomedicine. For example, quantum dots and CNTs have been used for in vivo imaging [95, 96], and nanofibers and nanoparticles have been used for gene/drug delivery [97, 98]. Moreover, magnetic nanoparticles were also used to induce hyperthermal tumor reduction ; Ag and Au nanoparticles  have bactericidal properties (Ag, Au ) whereas TiO2, ZnO, and organic  nanoparticles have been shown to have high UV absorbance. Recently, other versatile materials have been designed for high-precision sensing [101, 102].
Despite many biomedical-related applications of this class of nanomaterials, only a few applications on direct SC differentiation and maintenance have been reported in the literature. Meanwhile, these small building blocks can dramatically change the media properties, like hydrogels’ stiffness and polymers’ conductivity. Recently, it was reported that a hybrid hydrogel-CNTs reinforced scaffold induced a rapid hMSC proliferation . Their effect was due to the suitable mechanical properties of the scaffold. These properties could be achieved by controlling the CNT quantity, for the formation of specific tissues (e.g., cardiac ). The CNT were also incorporated in polymer matrices to fabricate electrically conductive scaffolds, aiming at differentiation and interaction with neural and cardiac cells via electric signals [103, 105, 106].
It is well known that nanomaterials in a biological fluid bind with proteins differently from plain substrates [75, 76, 90], forming an organized and complex (e.g., time-dependent) structure called the “protein corona.” Some common proteins, like albumin, immunoglobulin, and fibrinogen, are found to bind strongly to CNTs, iron oxide, and polymeric particles. The properties listed above (e.g., surface composition, hydrophobicity, and charge) influence the protein adsorption and mediate cell-NP interaction (e.g., binding, uptake). Therefore, the understanding of the formation of the protein corona is seen as one of the important objectives in bio-nanoscience [76, 90–93].
Ranging from microseconds to days , the duration of protein-nanoparticle interaction can be used for controllable protein delivery through to SC control. It can be directly introduced into nondegradable (or with difficult degradation rate control) scaffolds [10, 103] or in vivo , as was done before with other biochemical factors loaded into microspheres [107, 108]. Nanoparticle-protein interaction also represents a promising application of protein presentation in diversified conformations [1, 7, 76, 86, 109], which is an important issue in the SC fate selection.
Using nanomaterials, it is also possible to produce unique thin films. For example, TiO2 nanoparticles increase MSC attachment by altering surface roughness . In another study, the use of TiN nanoparticles also promotes hMSCs attachment. More than merely cell attachment, applications of these nanomaterial films can be extended, targeting protein binding and presentation as well as controllable hydrophobicity.
3.3. Two-Dimensional Nanomaterials
Biomaterial designed surfaces are the simplest, more controllable- and well-explored model for probing factors for controlling the cell fate (different ligand presentation strategy can be found in Figure 2(b)). The development of building and patterning techniques has made it easier to improve the understanding of cell biology over the smallest scale of the interaction between the cells and their natural niches. Furthermore, this development made it possible to mimic such niches by appropriate material patterns—from hydrogels using soft embossing technique to hard ceramics by electron beam lithography (EBL). The EBL technique—just one example among many useful techniques—can provide virtually any topographical nanoarchitecture desired (e.g., cones, tubes, pitches, and domes) in order to mimic the cell niche.
Cells have the ability to sense and adapt to these environmental nanofeatures, using their filopodia [17, 111–113]. Although this has been known, at least since 1952 , the improvement of fabrication techniques over the last decade has allowed the study of interactions at markedly smaller scales. Topography combined with material composition and hardness was shown to exert spatially resolved forces over the cells’ cytoskeleton [2, 16–18, 115–117], thereby modifying the cell shape and possibly controlling their fate. Chen et al. showed that smaller ECM islands change cell morphology (leading to a more rounded shape), profoundly altering the actin cytoskeleton and the organization of focal contacts [115, 116] (Figures 3(a) and 3(b)).
More examples of the options for nanoscale control over different cell types can be found elsewhere related to the dimensions and type of the nanostructure (e.g., grooves, pits, and pores) [16, 18, 112, 113, 118]. For example, an increase in the apoptotic response of endothelial cells was related to a decrease in the diameter of the cell’s culture size . Cell fate is therefore controlled by complex intracellular mechanisms affected not only by the size and type of nanostructure but also by symmetry. Highly ordered square nanoarrays produced by EBL induced low fibroblasts adhesion (Figure 4) . Moreover, normalised array data show broad downregulation of genes in fibroblasts cultured on hexagonal pattern, indicating that mechanical forces lead to changes in gene regulation . However, the same hexagonal symmetry of gold nanodots binding with integrin receptors has shown that separation between dots is an important factor to control cell adhesion and proliferation .
These and many other mechanisms can be used to direct SC growth and differentiation . The same mechanisms to control the cell shape, alignment, and adhesion using mimic-designed biomaterials were studied in order to control stem cell proliferation and differentiation . A similar effect of low adhesion induced by highly ordered nanotopographies was reported by Dalby et al., where they demonstrated significantly increased hMSC osteogenic differentiation . Mesenchymal stem cells also show clear alignment and elongation when cultured on a surface with nanogrooves [121, 122]. Yim et al. also reported that the upregulation of neuronal markers (SOX2, MAP2, neurofilament light peptide, and tyrosine hydroxylase) was observed and enhanced if the surface was coated with retinoic acid .
The above studies suggest that nanotopological cues may be used to direct hMSC and hESC into specific cell lineages. Acting as a component of the ECM, they change the cell shape—that is, modify the cytoskeleton structure—by controlling the number and density of focal adhesion sites in response to nanostructures shape, size, and symmetry (Figures 3(c) and 3(d)). A direct consequence is the change in the cell’s cytoskeleton’s structure which in turn activates specific genes via mechanotransduction mechanisms (Figure 3(c)), which are presently not fully understood. Moreover, nanotopography can be used as a spatially well-defined platform to exert proper presentation of immobilized biochemical factors (e.g., proteins, ligands, and radical groups) in order to control cell adhesion, migration, and differentiation [66, 123]. Furthermore, surface nanoarchitecturing can dramatically change the surface properties, for example, hydrophilicity  and biocompatibility .
Graphene is another 2D material being actively studied for SC support. Although it is a relatively new material, its surface properties were shown to promote growth and proliferation of hMSC on a range of graphene-coated substrates  and to enhance the differentiation of human neural stem cells (hNSC) . Moreover, graphene and graphene oxide were shown to stimulate hMSC differentiation toward the osteogenic lineage [126–128]. These materials were also studied as a platform for induced pluripotent SC and induced differentiation of these cells into an endodermal type .
3.4. Three-Dimensional Nanomaterials
The natural niche for tissue-specific adult SCs is not a plane surface. In contrast, it is three-dimensional and presents biological cues at different scales and directions (Figure 1(b)) [1, 7–9, 130]. Moreover, cells are not static and can “feel” the presence of tension and electrical signals in media. A 3D fibrous scaffold is a viable model to use as a mimic of body tissue when studying the proliferation and differentiation of SCs [131–133]. Whilst 2D materials represent a simple model for isolating the control factors for SCs in fundamental research, 3D materials possess a more complex architecture which can be tailored more precisely for real tissue engineering. The combination of these scaffolds and adult cells (e.g., fibroblasts and osteoblasts) for the regeneration of connective tissues is well documented [9, 134–138].
Commonly made of biopolymers, nanofibrous scaffolds (NFS) are used to support SC growth (attachment, proliferation, and organization) and differentiation [8, 10, 11, 70]. Recent studies reported that NFS can promote the differentiation of hMSCs even without intentional addition of growth factors . However, similar to other nanoarchitectured surfaces, nanofibers can also be designed for molecule/ligand presentation and delivery [140–142]. In addition to surface composition and mechanical properties, diffusion of GFs and migration of cells should be taken into account.
Nevertheless, the results previously discussed for 2D materials, such as cell alignment to substrate and controlling cell size and shape, also hold for 3D materials. For example, using the electrospinning technique, Li et al. produced and used polymer NFS to induce differentiation of hMSC into the chondrocyte lineage in order to substitute for the micromass cell pellet culture . The same group reported the differentiation of hMSCs from a single patient into adipogenic, chondrogenic, and osteogenic lineages utilizing the same NF matrix . The same technique was also used to produce aligned nano- and micro-FS . Neural SCs cultured on that media grew such that they were aligned with the fibers, independently of their diameter (Figure 4(c)). However, the differentiation rates were higher (as evidenced by a strong protein expression) on the nanofibrous rather than on the microfibrous scaffolds . Importantly, not only differentiation but SC proliferation was reported using synthetic polyamide NF matrix .
A notable advantage of these materials is the reasonably high level of control over elasticity, an important characteristic due to the strong influence over the SC fate [2, 145]. This property is hard to control when using 2D materials and can be set closer to the elasticity of biological tissues using nanofibers . Moreover, introduction of carbon nanotubes/fibers into polymeric matrices can lead to an increase in mechanical properties, electrical conductivity, and reactivity of the biomaterials [146, 147]. Recently, Subramony et al.  showed the time control of mechanical stimulation during MSC growth and its effects on cell differentiation. Mechanical tension combined with the matrix alignment led to the development of fibroblasts in vitro without any significant chemical influence.
Instead of polymers, another two classes of materials that are used for NF 3D scaffolds deserve specific attention, namely, carbon nanotubes/fibers and self-assembled peptide nanofibers (Figure 4(a)). Carbon nanomaterials have already been discussed in this review. Nevertheless, nanofibers of this abundant and nontoxic material have been effective in differentiating neural stem cells as well as offering good electrical conductivity, high reactivity , and increased absorption of laminin . On the other hand, some peptide sequences known to direct SC differentiation can self-assemble in order to form a high-density NF scaffold . Some useful characteristics of these peptide scaffolds are the high water content and the diffusion of nutrients, bioactive factors, and oxygen sufficient for the survival of large numbers of cells for extended periods of time .
4. Potential Use of Plasmas for Materials for Stem Cell Control
4.1. Plasma-Based Process Overview
Plasma-based synthesis and processing of nanomaterials are an interdisciplinary research field [14, 15, 149]. A wide range of applications resulted from the control over the properties involved in plasma-based systems such as source power, frequency, and chemistry. A range of species such as ions, electrons, atoms, and radicals are present in a plasma discharge. The principal property of plasma processes is the capability to deliver these species at a desired substrate with controllable energy, thus enabling nanoscale self-assembly [150–155] and deterministic fabrication of nanomaterials [14, 15, 152, 156–164]. Some examples of plasma-produced nanomaterials are presented in Figure 5. Interestingly, these carbon-based nanostructures—vertically aligned graphene and carbon nanotubes—can only be obtained via plasma-based processes .
The focus on direct medical applications of plasmas—where the related substrate can be a living tissue—is also increasing [166, 167]. For example, low-temperature plasmas have been used for treating diseases in animal models [88, 168, 169]. Reactive species produced in low-temperature plasma (e.g., free radicals as well as reactive oxygen and nitrogen species (ROS/RNS) such as O, OH, H2O2, O3, NO, and NO2) [169, 170]) have a fundamental role in chemical reactions, as they can be used to regulate the level of ROS and RNS in intracellular space in order to control cell fate [88, 167]. The role of ROS and RNS in cell control is widely studied; amongst other things they have been shown to influence cell “stemness”  and proliferation [172, 173].
Recently, atmospheric-pressure plasma jets showed a special selectivity, killing cancer cells without affecting normal cells . These and similar (e.g., dielectric barrier discharges) devices were also used under different doses to inactivate pathogens and microorganisms such as bacteria, fungi, and viruses [168, 169, 175]. This type of plasma has found numerous applications in medicine and several others such as sterilization of surgical instruments, skin, and wound disinfection/healing [88, 176–180]. Atmospheric pressure plasmas have also been demonstrated to support “plasma bullets” [181, 182]; such exotic structures are likely to lead to a range of promising medical applications and should be the subject of further investigation.
Control over SC fate mediated by plasmas is also possible; for example , atmospheric-pressure room-temperature plasmas can effectively induce in vitro differentiation of neural stem cells (NSCs) predominantly into neuronal lineage. After plasma treatment, the murine NSC exhibited rapid proliferation and differentiation into neurons with high efficiency.
There are, however, potential disadvantages associated with the use of plasmas for direct medical application; these are largely related to the presence of plasma-generated energetic ROS/RNS and UV radiation . Studies have shown that, depending on the specific conditions (i.e., plasma dose/irradiation and cell type), plasmas may affect cell properties (i.e., adhesion, membrane permeability, migration, and apoptosis/necrosis) and possibly damage DNA and modify proteins . Further study and clinical trials are required before practical use of plasmas as direct medical tools.
Plasmas may also be used to fabricate micro- and nanostructures (see Figure 5) as well as appropriately functionalized surfaces, suitable for SC control. The aim of the rest of this section is to track where plasma technologies have an implication over materials production and modification for stem cell control and highlight where it could have potential uses.
4.2. Plasma-Based Nanofabrication
The existence of energetic species in plasmas makes it suitable for dry etching applications and many other materials synthesis and processing [152, 157, 159, 163, 185]. These techniques can produce patterns in hard materials at micro- and nanoscales. These patterns in turn can be used to control the alignment and shape of SCs. The material removed from a target using plasmas can also be used for functional thin film deposition, with almost no restriction over the target composition or substrate shape—which is an advantage for coating 3D materials [14, 15, 149, 186]. Moreover, the properties of these thin films can be precisely tailored, for example, to enable degradation after use [159, 187]. Other considerations for biological applications are the production time and cost , which can be reduced in plasma processes [151, 153, 188].
The applications, namely, etching, deposition and, surface modification, are the most common in literature, although plasma-based processes are capable of producing a variety of nanomaterials [151, 189], namely, nanoparticles [190, 191], nanodots [155, 192], and various allotropes of carbon (e.g., nanodiamond , nanotubes [158, 189], nanocones , nanowalls, and graphene [102, 160, 161, 194]). Plasma techniques also provide the control over the properties of these nanomaterials (e.g., size, shape, and surface reactivity) [99, 152, 157, 162, 163, 195]. As discussed above, these properties are essential to bind proteins and cells, as well as for the delivery of specific (e.g., differentiation) factors in order to control the SC fate. Moreover, due to the unique ability to dissociate molecules (e.g., hydrogen), the control over some properties is not achievable by other techniques such as neutral gas-based CVD or by wet chemistry routes .
The control over the nanostructural properties is related to the plasma ability to generate and concentrate building units (BU) of nanoscale matter [15, 99]. Moreover, these BU can be directly delivered to a substrate and build a wide range of complex architectures discussed previously to mimic the SC natural niche and control cell fate. The plasma environments have specific features and control self-assembly of nanostructures into patterns and arrays (often termed “mask-less”). Plasma processes have also been reported to lead to a sustainable energy saving and reduction of greenhouse emissions. Interestingly, carbon nanotubes and other one-dimensional nanostructures show pronounced vertical alignment which is not common to thermal CVD .
For the same reason, plasma-based technologies have long been reported as an effective route for surface treatment . The importance of this fact is, for example, the ability to chemically improve the biocompatibility of the surface by increasing its hydrophilicity, which in turn increases the cell proliferation [8, 158, 163]. Moreover, several limitations (e.g., control over chemical properties and difficulties in sterilization) could be overcome by plasma-based techniques. Furthermore, plasma-based techniques were used to functionalize important nanomaterials such as CNTs leading to better substrates for the enhancement of cell growth and proliferation .
Regarding the control of SC fate, it is well known that the proliferation (without differentiation) or the differentiation to desired lineages requires both growth factors and, for some specific SC, mechanical stimulation. Several strategies can be followed to reach this goal, for example, production of specific tailored nanostructures with or without bound/immobilised growth factors that directly promote SC expansion or controlled differentiation. These nanostructures can be added to hydrogels/nanoscaffolds in order to temporally control the delivery of GFs and migration of cells. Surfaces can also be plasma-tailored with desired nanostructures to mechanically guide the SC via focal contact or be used as binding point to ligands/chemical radicals or both, leading to SC proliferation/differentiation according to the input stimulus.
An example involving a plasma-treated nanostructure coated with a specific GF was reported by Arnold et al. . In order to understand the role of a precise molecular arrangement on cell response, a substrate was patterned with Au nanodots (<8 nm), highly ordered with controllable distances, via self-assembly of diblock copolymer micelles. After the assembly of the nanodots, the polymer was completely removed by the plasma treatment and the dot-patterned substrate was functionalized with a specific peptide (c(RGDfK)), which has a high affinity to the ανβ-integrin. Due to the small surface area of the nanodot, only one integrin can attach to each dot and the effect of the arranged binding sites could be studied. Such an approach is powerful as it enables control over the presentation of mass amounts of specific signals/ligands at precise spatial locations and size scales and therefore an ability to dissect how cells respond to variations in ligand density. There is great potential to exploit this approach to critically examine the presentation of defined amounts of combinations of biological signals to stem cells. We predict that sophisticated nanoengineering based on plasma generated biomaterials will underpin a new era in cell culture.
5. Conclusions and Challenges for Future Research
In this review, we have discussed sources and applications of SCs and the mechanisms by which they can be controlled and subsequently, the use of nanomaterials to control SCs. We have pointed out the properties that make low-temperature plasmas a suitable tool to use in the production and functionalization of these NMs for more effective and specific interaction with SCs, both through direct treatment and as a versatile nanofabrication tool .
Due to the many unique characteristics of low-temperature plasmas, we believe that the direct use of plasmas, especially atmospheric plasmas, should be considered as a viable strategy to direct SC differentiation. Plasmas as a nanofabrication tool should be focused on developing “lab on a chip” devices as suitable platforms for the differentiation of SCs into any cell lineage through mechanical and/or electrical stimulus.
Tissue engineering and SC biology can benefit greatly from advances in plasma nanoscience . Nanomaterial design is leading to a greater degree of control over cell attachment and migration in order to grow multilevel tissues (or organs, e.g., skin). This control also contributes to basic studies on mimicking ECM properties and ligands quantity and presentation as well as elucidating the role of time in growth factors delivery.
F. F. Borghi acknowledges the support from the Science Without Borders Program of the Brazilian Government, A. E. Rider and Z. J. Han acknowledge the support from the CSIRO Sensors and Sensor Network TCP, and A. E. Rider and S. Kumar acknowledge the support from the CSIRO OCE Postdoctoral Fellowship schemes. This work is partially supported by the Australian Research Council (ARC) and CSIRO’s OCE Science Leadership Program.
- K. Saha, J. F. Pollock, D. V. Schaffer, and K. E. Healy, “Designing synthetic materials to control stem cell phenotype,” Current Opinion in Chemical Biology, vol. 11, no. 4, pp. 381–387, 2007.
- A. J. Engler, S. Sen, H. L. Sweeney, and D. E. Discher, “Matrix elasticity directs stem cell lineage specification,” Cell, vol. 126, no. 4, pp. 677–689, 2006.
- J. A. Burdick and G. Vunjak-Novakovic, “Engineered microenvironments for controlled stem cell differentiation,” Tissue Engineering A, vol. 15, no. 2, pp. 205–219, 2009.
- G. H. Altman, R. L. Horan, I. Martin et al., “Cell differentiation by mechanical stress,” The FASEB Journal, vol. 16, no. 2, pp. 270–272, 2002.
- D. L. Butler, N. Juncosa-Melvin, G. P. Boivin et al., “Functional tissue engineering for tendon repair: a multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation,” Journal of Orthopaedic Research, vol. 26, no. 1, pp. 1–9, 2008.
- V. Terraciano, N. Hwang, L. Moroni et al., “Differential response of adult and embryonic mesenchymal progenitor cells to mechanical compression in hydrogels,” Stem Cells, vol. 25, no. 11, pp. 2730–2738, 2007.
- M. P. Lutolf, P. M. Gilbert, and H. M. Blau, “Designing materials to direct stem-cell fate,” Nature, vol. 462, no. 7272, pp. 433–441, 2009.
- E. Dawson, G. Mapili, K. Erickson, S. Taqvi, and K. Roy, “Biomaterials for stem cell differentiation,” Advanced Drug Delivery Reviews, vol. 60, no. 2, pp. 215–228, 2008.
- N. S. Hwang, S. Varghese, and J. Elisseeff, “Controlled differentiation of stem cells,” Advanced Drug Delivery Reviews, vol. 60, no. 2, pp. 199–214, 2008.
- C. Chai and K. W. Leong, “Biomaterials approach to expand and direct differentiation of stem cells,” Molecular Therapy, vol. 15, no. 3, pp. 467–480, 2007.
- C. Cha, W. B. Liechty, A. Khademhosseini, and N. A. Peppas, “Designing biomaterials to direct stem cell fate,” ACS Nano, vol. 6, no. 11, pp. 9353–9358, 2012.
- T. M. A. Henderson, K. Ladewig, D. N. Haylock, K. M. Mclean, and A. J. O. Connor, “Cryogels for biomedical applications,” Journal of Materials Chemistry B, vol. 1, pp. 2682–2695, 2013.
- J. Nigro, J. F. White, J. A. M. Ramshaw, D. N. Haylock, S. K. Nilsson, and J. A. Werkmeister, “The effect of bovine endosteum-derived particles on the proliferation of human mesenchymal stem cells,” Biomaterials, vol. 31, no. 21, pp. 5689–5699, 2010.
- K. Ostrikov, U. Cvelbar, and A. B. Murphy, “Plasma nanoscience: setting directions, tackling grand challenges,” Journal of Physics D, vol. 44, no. 17, Article ID 174001, 2011.
- K. Ostrikov, E. C. Neyts, and M. Meyyappan, “Plasma nanoscience: from nano-solids in plasmas to nano-plasmas in solids,” Advances in Physics, vol. 62, no. 2, pp. 113–224, 2013.
- C. S. Chen, M. Mrksich, S. Huang, G. M. Whitesides, and D. E. Ingber, “Geometric control of cell life and death,” Science, vol. 276, no. 5317, pp. 1425–1428, 1997.
- F. Guilak, D. M. Cohen, B. T. Estes, J. M. Gimble, W. Liedtke, and C. S. Chen, “Control of stem cell fate by physical interactions with the extracellular matrix,” Cell Stem Cell, vol. 5, no. 1, pp. 17–26, 2009.
- M. J. Dalby, N. Gadegaard, R. Tare et al., “The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder,” Nature Materials, vol. 6, no. 12, pp. 997–1003, 2007.
- G. A. Silva, C. Czeisler, K. L. Niece et al., “Selective differentiation of neural progenitor cells by high-epitope density nanofibers,” Science, vol. 303, no. 5662, pp. 1352–1355, 2004.
- F. Yang, R. Murugan, S. Wang, and S. Ramakrishna, “Electrospinning of nano/micro scale poly(l-lactic acid) aligned fibers and their potential in neural tissue engineering,” Biomaterials, vol. 26, no. 15, pp. 2603–2610, 2005.
- K. Okita, T. Ichisaka, and S. Yamanaka, “Generation of germline-competent induced pluripotent stem cells,” Nature, vol. 448, no. 7151, pp. 313–317, 2007.
- M. Wernig, A. Meissner, R. Foreman et al., “In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state,” Nature, vol. 448, no. 7151, pp. 318–324, 2007.
- M. Mimeault and S. K. Batra, “Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies,” Stem Cells, vol. 24, no. 11, pp. 2319–2345, 2006.
- C. Fehrer and G. Lepperdinger, “Mesenchymal stem cell aging,” Experimental Gerontology, vol. 40, no. 12, pp. 926–930, 2005.
- A. Stolzing and A. Scutt, “Age-related impairment of mesenchymal progenitor cell function,” Aging Cell, vol. 5, no. 3, pp. 213–224, 2006.
- L. B. To, D. N. Haylock, P. J. Simmons, and C. A. Juttner, “The biology and clinical uses of blood stem cells,” Blood, vol. 89, no. 7, pp. 2233–2258, 1997.
- M. J. Evans and M. H. Kaufman, “Establishment in culture of pluripotential cells from mouse embryos,” Nature, vol. 292, no. 5819, pp. 154–156, 1981.
- L. Jakobsson, J. Kreuger, and L. Claesson-Welsh, “Building blood vessels—stem cell models in vascular biology,” The Journal of Cell Biology, vol. 177, no. 5, pp. 751–755, 2007.
- S.-I. Nishikawa, L. M. Jakt, and T. Era, “Embryonic stem-cell culture as a tool for developmental cell biology,” Nature Reviews Molecular Cell Biology, vol. 8, no. 6, pp. 502–507, 2007.
- D. J. Prockop, “Marrow stromal cells as stem cells for nonhematopoietic tissues,” Science, vol. 276, no. 5309, pp. 71–74, 1997.
- M. F. Pittenger, “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999.
- J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147, 1998.
- K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006.
- M. Tada, Y. Takahama, K. Abe, N. Nakatsuji, and T. Tada, “Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells,” Current Biology, vol. 11, no. 19, pp. 1553–1558, 2001.
- G. Bianchi, A. Banfi, M. Mastrogiacomo et al., “Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2,” Experimental Cell Research, vol. 287, no. 1, pp. 98–105, 2003.
- I. Martin, A. Muraglia, G. Campanile, R. Cancedda, and R. Quarto, “Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow,” Endocrinology, vol. 138, no. 10, pp. 4456–4462, 1997.
- L. A. Solchaga, K. Penick, J. D. Porter, V. M. Goldberg, A. I. Caplan, and J. F. Welter, “FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells,” Journal of Cellular Physiology, vol. 203, no. 2, pp. 398–409, 2005.
- S. Tsutsumi, A. Shimazu, K. Miyazaki et al., “Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF,” Biochemical and Biophysical Research Communications, vol. 288, no. 2, pp. 413–419, 2001.
- H. J. Rippon, J. M. Polak, M. Qin, and A. E. Bishop, “Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol,” Stem Cells, vol. 24, no. 5, pp. 1389–1398, 2006.
- M. Nakanishi, T. S. Hamazaki, S. Komazaki, H. Okochi, and M. Asashima, “Pancreatic tissue formation from murine embryonic stem cells in vitro,” Differentiation, vol. 75, no. 1, pp. 1–11, 2007.
- D. T. Scadden, “The stem-cell niche as an entity of action,” Nature, vol. 441, no. 7097, pp. 1075–1079, 2006.
- S. J. Morrison and A. C. Spradling, “Stem cells and niches: mechanisms that promote stem cell maintenance throughout life,” Cell, vol. 132, no. 4, pp. 598–611, 2008.
- R. Peerani and P. W. Zandstra, “Enabling stem cell therapies through synthetic stem cell-niche engineering,” The Journal of Clinical Investigation, vol. 120, no. 1, pp. 60–70, 2010.
- P. M. Gilbert and H. M. Blau, “Engineering a stem cell house into a home,” Stem Cell Research & Therapy, vol. 2, no. 1, article 3, 2011.
- D. N. Haylock and P. J. Simmons, “Approaches to hematopoietic stem cell separation and expansion,” in Handbook on Adult Stem Cell Biology, p. 615, Elsevier/Academic Press, San Diego, Calif, USA, 2004.
- A. S. Hoffman, “Hydrogels for biomedical applications,” Advanced Drug Delivery Reviews, vol. 54, no. 1, pp. 3–12, 2002.
- J. L. Drury and D. J. Mooney, “Hydrogels for tissue engineering: scaffold design variables and applications,” Biomaterials, vol. 24, no. 24, pp. 4337–4351, 2003.
- J. Kopeček and J. Yang, “Hydrogels as smart biomaterials,” Polymer International, vol. 56, no. 9, pp. 1078–1098, 2007.
- J. A. Hubbell, “Biomaterials in tissue engineering,” Biotechnology, vol. 13, no. 6, pp. 565–576, 1995.
- W. E. Hennink and C. F. van Nostrum, “Novel crosslinking methods to design hydrogels,” Advanced Drug Delivery Reviews, vol. 54, no. 1, pp. 13–36, 2002.
- C. Xu, M. S. Inokuma, J. Denham et al., “Feeder-free growth of undifferentiated human embryonic stem cells,” Nature Biotechnology, vol. 19, no. 10, pp. 971–974, 2001.
- M. Amit, C. Shariki, V. Margulets, and J. Itskovitz-Eldor, “Feeder layer- and serum-free culture of human embryonic stem cells,” Biology of Reproduction, vol. 70, no. 3, pp. 837–845, 2004.
- G. M. Beattie, A. D. Lopez, N. Bucay et al., “Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers,” Stem Cells, vol. 23, no. 4, pp. 489–495, 2005.
- S. Battista, D. Guarnieri, C. Borselli et al., “The effect of matrix composition of 3D constructs on embryonic stem cell differentiation,” Biomaterials, vol. 26, no. 31, pp. 6194–6207, 2005.
- C.-F. Chang, M.-W. Lee, P.-Y. Kuo, Y.-J. Wang, Y.-H. Tu, and S.-C. Hung, “Three-dimensional collagen fiber remodeling by mesenchymal stem cells requires the integrin-matrix interaction,” Journal of Biomedical Materials Research A, vol. 80, no. 2, pp. 466–474, 2007.
- K. E. McCloskey, M. E. Gilroy, and R. M. Nerem, “Use of embryonic stem cell-derived endothelial cells as a cell source to generate vessel structures in vitro,” Tissue Engineering, vol. 11, no. 3-4, pp. 497–505, 2005.
- M. S. Ponticiello, R. M. Schinagl, S. Kadiyala, and F. P. Barry, “Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy,” Journal of Biomedical Materials Research, vol. 52, no. 2, pp. 246–255, 2000.
- S. Tielens, H. Declercq, T. Gorski, E. Lippens, E. Schacht, and M. Cornelissen, “Gelatin-based microcarriers as embryonic stem cell delivery system in bone tissue engineering: an in-vitro study,” Biomacromolecules, vol. 8, no. 3, pp. 825–832, 2007.
- S. Gerecht, J. A. Burdick, L. S. Ferreira, S. A. Townsend, R. Langer, and G. Vunjak-Novakovic, “Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 27, pp. 11298–11303, 2007.
- C. Ventura, M. Maioli, Y. Asara et al., “Butyric and retinoic mixed ester of hyaluronan: a novel differentiating glycoconjugate affording a high throughput of cardiogenesis in embryonic stem cells,” The Journal of Biological Chemistry, vol. 279, no. 22, pp. 23574–23579, 2004.
- T. Maguire, A. E. Davidovich, E. J. Wallenstein et al., “Control of hepatic differentiation via cellular aggregation in an alginate microenvironment,” Biotechnology and Bioengineering, vol. 98, no. 3, pp. 631–644, 2007.
- M. Ruhnke, H. Ungefroren, G. Zehle, M. Bader, B. Kremer, and F. Fändrich, “Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages,” Stem Cells, vol. 21, no. 4, pp. 428–436, 2003.
- V. Planat-Benard, J.-S. Silvestre, B. Cousin et al., “Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives,” Circulation, vol. 109, no. 5, pp. 656–663, 2004.
- C. Xu, J.-Q. He, T. J. Kamp et al., “Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum,” Stem Cells and Development, vol. 15, no. 6, pp. 931–941, 2006.
- H. J. Lee, J.-S. Lee, T. Chansakul, C. Yu, J. H. Elisseeff, and S. M. Yu, “Collagen mimetic peptide-conjugated photopolymerizable PEG hydrogel,” Biomaterials, vol. 27, no. 30, pp. 5268–5276, 2006.
- R. McBeath, D. M. Pirone, C. M. Nelson, K. Bhadriraju, and C. S. Chen, “Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment,” Developmental Cell, vol. 6, no. 4, pp. 483–495, 2004.
- F. Yang, C. G. Williams, D.-A. Wang, H. Lee, P. N. Manson, and J. Elisseeff, “The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells,” Biomaterials, vol. 26, no. 30, pp. 5991–5998, 2005.
- C. R. Nuttelman, M. C. Tripodi, and K. S. Anseth, “In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels,” Journal of Biomedical Materials Research A, vol. 68, no. 4, pp. 773–782, 2004.
- Y. D. Teng, E. B. Lavik, X. Qu et al., “Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 3024–3029, 2002.
- S. Levenberg, N. F. Huang, E. Lavik, A. B. Rogers, J. Itskovitz-Eldor, and R. Langer, “Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 22, pp. 12741–12746, 2003.
- M. J. Mondrinos, S. Koutzaki, E. Jiwanmall et al., “Engineering three-dimensional pulmonary tissue constructs,” Tissue Engineering, vol. 12, no. 4, pp. 717–728, 2006.
- C. S. Young, H. Abukawa, R. Asrican et al., “Tissue-engineered hybrid tooth and bone,” Tissue Engineering, vol. 11, no. 9-10, pp. 1599–1610, 2005.
- D. E. Discher, P. Janmey, and Y.-L. Wang, “Tissue cells feel and respond to the stiffness of their substrate,” Science, vol. 310, no. 5751, pp. 1139–1143, 2005.
- E. K. F. Yim and K. W. Leong, “Significance of synthetic nanostructures in dictating cellular response,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 1, no. 1, pp. 10–21, 2005.
- T. Cedervall, I. Lynch, S. Lindman et al., “Understanding the nanoparticle-protein corona using methods to quntify exchange rates and affinities of proteins for nanoparticles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2050–2055, 2007.
- M. Lundqvist, J. Stigler, G. Elia, I. Lynch, T. Cedervall, and K. A. Dawson, “Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14265–14270, 2008.
- H. V. Unadkat, M. Hulsman, K. Cornelissen et al., “An algorithm-based topographical biomaterials library to instruct cell fate,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 40, pp. 16565–16570, 2011.
- G. M. Whitesides, E. Ostuni, S. Takayama, X. Jiang, and D. E. Ingber, “Soft lithography in biology and biochemistry,” Annual Review of Biomedical Engineering, vol. 3, pp. 335–373, 2001.
- J. J. Norman and T. A. Desai, “Methods for fabrication of nanoscale topography for tissue engineering scaffolds,” Annals of Biomedical Engineering, vol. 34, no. 1, pp. 89–101, 2006.
- A. Khademhosseini, R. Langer, J. Borenstein, and J. P. Vacanti, “Microscale technologies for tissue engineering and biology,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2480–2487, 2006.
- D. Falconnet, G. Csucs, H. M. Grandin, and M. Textor, “Surface engineering approaches to micropattern surfaces for cell-based assays,” Biomaterials, vol. 27, no. 16, pp. 3044–3063, 2006.
- B. G. Keselowsky, D. M. Collard, and A. J. García, “Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 5953–5957, 2005.
- A. J. García, M. D. Vega, and D. Boettiger, “Modulation of cell proliferation and differentiation through substrate- dependent changes in fibronectin conformation,” Molecular Biology of the Cell, vol. 10, no. 3, pp. 785–798, 1999.
- W. G. Brodbeck, J. Patel, G. Voskerician et al., “Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 16, pp. 10287–10292, 2002.
- P. X. Ma, “Biomimetic materials for tissue engineering,” Advanced Drug Delivery Reviews, vol. 60, no. 2, pp. 184–198, 2008.
- D. Walczyk, F. B. Bombelli, M. P. Monopoli, I. Lynch, and K. A. Dawson, “What the cell “sees” in bionanoscience,” Journal of the American Chemical Society, vol. 132, no. 16, pp. 5761–5768, 2010.
- M.-E. Aubin-Tam and K. Hamad-Schifferli, “Structure and function of nanoparticle-protein conjugates,” Biomedical Materials, vol. 3, no. 3, Article ID 034001, 2008.
- M. G. Kong, M. Keidar, and K. Ostrikov, “Plasmas meet nanoparticles-where synergies can advance the frontier of medicine,” Journal of Physics D, vol. 44, no. 17, Article ID 174018, 2011.
- Q. A. Pankhurst, J. Connolly, S. K. Jones, and J. Dobson, “Applications of magnetic nanoparticles in biomedicine,” Journal of Physics D, vol. 36, no. 13, pp. R167–R181, 2003.
- T. Cedervall, I. Lynch, M. Foy et al., “Detailed identification of plasma proteins adsorbed on copolymer nanoparticles,” Angewandte Chemie—International Edition, vol. 46, no. 30, pp. 5754–5756, 2007.
- A. E. Nel, L. Mädler, D. Velegol et al., “Understanding biophysicochemical interactions at the nano-bio interface,” Nature Materials, vol. 8, no. 7, pp. 543–557, 2009.
- P. Decuzzi and M. Ferrari, “The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles,” Biomaterials, vol. 28, no. 18, pp. 2915–2922, 2007.
- H. Gao, W. Shi, and L. B. Freund, “Mechanics of receptor-mediated endocytosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 27, pp. 9469–9474, 2005.
- C. C. Fleck and R. R. Netz, “Electrostatic colloid-membrane binding,” Europhysics Letters, vol. 67, no. 2, pp. 314–320, 2004.
- P. W. Barone, H. Yoon, R. Ortiz-García et al., “Modulation of single-walled carbon nanotube photoluminescence by hydrogel swelling,” ACS Nano, vol. 3, no. 12, pp. 3869–3877, 2009.
- C. Zavaleta, A. de la Zerda, Z. Liu et al., “Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes,” Nano Letters, vol. 8, no. 9, pp. 2800–2805, 2008.
- H. Valo, L. Peltonen, S. Vehviläinen et al., “Electrospray encapsulation of hydrophilic and hydrophobic drugs in poly(L-lactic acid) nanoparticles,” Small, vol. 5, no. 15, pp. 1791–1798, 2009.
- T. E. McKnight, A. V. Melechko, D. K. Hensley, D. G. J. Mann, G. D. Griffin, and M. L. Simpson, “Tracking gene expression after DNA delivery using spatially indexed nanofiber arrays,” Nano Letters, vol. 4, no. 7, pp. 1213–1219, 2004.
- Z. J. Han, I. Levchenko, S. Kumar et al., “Plasma nanofabrication and nanomaterials safety,” Journal of Physics D, vol. 44, no. 17, Article ID 174019, 2011.
- F. J. Aparicio, M. Holgado, A. Borras et al., “Transparent nanometric organic luminescent films as UV-active components in photonic structures,” Advanced Materials, vol. 23, no. 6, pp. 761–765, 2011.
- Y. Zhang, T. R. Nayak, H. Hong, and W. Cai, “Graphene: a versatile nanoplatform for biomedical applications,” Nanoscale, vol. 4, no. 13, pp. 3833–3842, 2012.
- A. E. Rider, S. Kumar, S. A. Furman, and K. Ostrikov, “Self-organized Au nanoarrays on vertical graphenes: an advanced three-dimensional sensing platform,” Chemical Communications, vol. 48, no. 21, pp. 2659–2661, 2012.
- S. R. Shin, H. Bae, J. M. Cha et al., “Carbon nanotube reinforced hybrid microgels as scaffold materials for cell encapsulation,” ACS Nano, vol. 6, no. 1, pp. 362–372, 2012.
- S. R. Shin, S. M. Jung, M. Zalabany et al., “Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators,” ACS Nano, vol. 7, no. 3, pp. 2369–2380, 2013.
- C. Lau, M. J. Cooney, and P. Atanassov, “Conductive macroporous composite chitosan-carbon nanotube scaffolds,” Langmuir, vol. 24, no. 13, pp. 7004–7010, 2008.
- N. W. S. Kam, E. Jan, and N. A. Kotov, “Electrical stimulation of neural stem cells mediated by humanized carbon nanotube composite made with extracellular matrix protein,” Nano Letters, vol. 9, no. 1, pp. 273–278, 2009.
- M. Yamamoto and Y. Tabata, “Tissue engineering by modulated gene delivery,” Advanced Drug Delivery Reviews, vol. 58, no. 4, pp. 535–554, 2006.
- M. C. Wake, P. D. Gerecht, L. Lu, and A. G. Mikos, “Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro,” Biomaterials, vol. 19, no. 14, pp. 1255–1268, 1998.
- F. Meder, J. Wehling, A. Fink et al., “The role of surface functionalization of colloidal alumina particles on their controlled interactions with viruses,” Biomaterials, vol. 34, no. 17, pp. 4203–4213, 2013.
- D. S. Kommireddy, S. M. Sriram, Y. M. Lvov, and D. K. Mills, “Stem cell attachment to layer-by-layer assembled TiO2 nanoparticle thin films,” Biomaterials, vol. 27, no. 24, pp. 4296–4303, 2006.
- R. G. Flemming, C. J. Murphy, G. A. Abrams, S. L. Goodman, and P. F. Nealey, “Effects of synthetic micro- and nano-structured surfaces on cell behavior,” Biomaterials, vol. 20, no. 6, pp. 573–588, 1999.
- A. S. G. Curtis, N. Gadegaard, M. J. Dalby, M. O. Riehle, C. D. W. Wilkinson, and G. Aitchison, “Cells react to nanoscale order and symmetry in their surroundings,” IEEE Transactions on Nanobioscience, vol. 3, no. 1, pp. 61–65, 2004.
- M. J. Dalby, N. Gadegaard, M. O. Riehle, C. D. W. Wilkinson, and A. S. G. Curtis, “Investigating filopodia sensing using arrays of defined nano-pits down to 35 nm diameter in size,” The International Journal of Biochemistry & Cell Biology, vol. 36, no. 10, pp. 2005–2015, 2004.
- P. Weiss and B. Garber, “Shape and movement of mesenchyme cells as functions of the physical structure of the medium. Contributions to a quantitative morphology,” Proceedings of the National Academy of Sciences of the United States of America, vol. 38, pp. 264–280, 1952.
- C. S. Chen, J. L. Alonso, E. Ostuni, G. M. Whitesides, and D. E. Ingber, “Cell shape provides global control of focal adhesion assembly,” Biochemical and Biophysical Research Communications, vol. 307, no. 2, pp. 355–361, 2003.
- C. S. Chen, M. Mrksich, S. Huang, G. M. Whitesides, and D. E. Ingber, “Micropatterned surfaces for control of cell shape, position, and function,” Biotechnology Progress, vol. 14, no. 3, pp. 356–363, 1998.
- M. J. Dalby, M. J. P. Biggs, N. Gadegaard, G. Kalna, C. D. W. Wilkinson, and A. S. G. Curtis, “Nanotopographical stimulation of mechanotransduction and changes in interphase centromere positioning,” Journal of Cellular Biochemistry, vol. 100, no. 2, pp. 326–338, 2007.
- N. Gadegaard, S. Thoms, D. S. Macintyre et al., “Arrays of nano-dots for cellular engineering,” Microelectronic Engineering, vol. 67-68, pp. 162–168, 2003.
- M. Arnold, E. A. Cavalcanti-Adam, R. Glass et al., “Activation of integrin function by nanopatterned adhesive interfaces,” ChemPhysChem, vol. 5, no. 3, pp. 383–388, 2004.
- P. J. Simmons, D. N. Haylock, and J. P. Lévesque, “Influence of cytokines and adhesion molecules on hematopoietic stem cell development,” in Ex Vivo Cell Therapy, pp. 51–83, Elsevier, San Diego, Calif, USA, 1999.
- E. K. F. Yim, S. W. Pang, and K. W. Leong, “Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage,” Experimental Cell Research, vol. 313, no. 9, pp. 1820–1829, 2007.
- S. Gerecht, C. J. Bettinger, Z. Zhang, J. T. Borenstein, G. Vunjak-Novakovic, and R. Langer, “The effect of actin disrupting agents on contact guidance of human embryonic stem cells,” Biomaterials, vol. 28, no. 28, pp. 4068–4077, 2007.
- J. M. Curran, R. Chen, and J. A. Hunt, “The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate,” Biomaterials, vol. 27, no. 27, pp. 4783–4793, 2006.
- T. R. Nayak, H. Andersen, V. S. Makam et al., “Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells,” ACS Nano, vol. 5, no. 6, pp. 4670–4678, 2011.
- S. Y. Park, J. Park, S. H. Sim et al., “Enhanced differentiation of human neural stem cells into neurons on graphene,” Advanced Materials, vol. 23, no. 36, pp. H263–H267, 2011.
- W. C. Lee, C. H. Y. X. Lim, H. Shi et al., “Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide,” ACS Nano, vol. 5, no. 9, pp. 7334–7341, 2011.
- S. W. Crowder, D. Prasai, R. Rath et al., “Three-dimensional graphene foams promote osteogenic differentiation of human mesenchymal stem cells,” Nanoscale, vol. 5, no. 10, pp. 4171–4176, 2013.
- O. Akhavan, E. Ghaderi, and M. Shahsavar, “Graphene nanogrids for selective and fast osteogenic differentiation of human mesenchymal stem cells,” Carbon, vol. 59, pp. 200–211, 2013.
- G.-Y. Chen, D. W.-P. Pang, S.-M. Hwang, H.-Y. Tuan, and Y.-C. Hu, “A graphene-based platform for induced pluripotent stem cells culture and differentiation,” Biomaterials, vol. 33, no. 2, pp. 418–427, 2012.
- D. N. Haylock and S. K. Nilsson, “Stem cell regulation by the hematopoietic stem cell niche,” Cell Cycle, vol. 4, no. 10, pp. 1353–1355, 2005.
- Z. J. Han, A. E. Rider, M. Ishaq et al., “Carbon nanostructures for hard tissue engineering,” RSC Advances, vol. 3, no. 28, pp. 11058–11072, 2013.
- S. Zhang, “Fabrication of novel biomaterials through molecular self-assembly,” Nature Biotechnology, vol. 21, no. 10, pp. 1171–1178, 2003.
- A. Nur-E-Kamal, I. Ahmed, J. Kamal, M. Schindler, and S. Meiners, “Three-dimensional nanofibrillar surfaces promote self-renewal in mouse embryonic stem cells,” Stem Cells, vol. 24, no. 2, pp. 426–433, 2006.
- S. Subramony, B. Dargis, and M. Castillo, “The guidance of stem cell differentiation by substrate alignment and mechanical stimulation,” Biomaterials, vol. 34, no. 8, pp. 1942–1953, 2012.
- H. Liu and K. Roy, “Biomimetic three-dimensional cultures significantly increase hematopoietic differentiation efficacy of embryonic stem cells,” Tissue Engineering, vol. 11, no. 1-2, pp. 319–330, 2005.
- H. Tanaka, C. L. Murphy, C. Murphy, M. Kimura, S. Kawai, and J. M. Polak, “Chondrogenic differentiation of murine embryonic stem cells: effects of culture conditions and dexamethasone,” Journal of Cellular Biochemistry, vol. 93, no. 3, pp. 454–462, 2004.
- E. Hadjipanayi, V. Mudera, and R. A. Brown, “Close dependence of fibroblast proliferation on collagen scaffold matrix stiffness,” Journal of Tissue Engineering and Regenerative Medicine, vol. 3, no. 2, pp. 77–84, 2009.
- E. Cukierman, R. Pankov, and K. M. Yamada, “Cell interactions with three-dimensional matrices,” Current Opinion in Cell Biology, vol. 14, no. 5, pp. 633–639, 2002.
- M. D. Schofer, U. Boudriot, C. Wack et al., “Influence of nanofibers on the growth and osteogenic differentiation of stem cells: a comparison of biological collagen nanofibers and synthetic PLLA fibers,” Journal of Materials Science: Materials in Medicine, vol. 20, no. 3, pp. 767–774, 2009.
- Y. Soen, A. Mori, T. D. Palmer, and P. O. Brown, “Exploring the regulation of human neural precursor cell differentiation using arrays of signaling microenvironments,” Molecular Systems Biology, vol. 2, article 37, 2006.
- E. Garreta, E. Genové, S. Borrós, and C. E. Semino, “Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-assembling peptide scaffold,” Tissue Engineering, vol. 12, no. 8, pp. 2215–2227, 2006.
- I. Ahmed, A. S. Ponery, A. Nur-E-Kamal et al., “Morphology, cytoskeletal organization, and myosin dynamics of mouse embryonic fibroblasts cultured on nanofibrillar surfaces,” Molecular and Cellular Biochemistry, vol. 301, no. 1-2, pp. 241–249, 2007.
- W.-J. Li, R. Tuli, C. Okafor et al., “A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells,” Biomaterials, vol. 26, no. 6, pp. 599–609, 2005.
- W.-J. Li, R. Tuli, X. Huang, P. Laquerriere, and R. S. Tuan, “Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold,” Biomaterials, vol. 26, no. 25, pp. 5158–5166, 2005.
- J. Holst, S. Watson, M. S. Lord et al., “Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells,” Nature Biotechnology, vol. 28, no. 10, pp. 1123–1128, 2010.
- G. Wei and P. X. Ma, “Partially nanofibrous architecture of 3D tissue engineering scaffolds,” Biomaterials, vol. 30, no. 32, pp. 6426–6434, 2009.
- S.-F. Wang, L. Shen, W.-D. Zhang, and Y.-J. Tong, “Preparation and mechanical properties of chitosan/carbon nanotubes composites,” Biomacromolecules, vol. 6, no. 6, pp. 3067–3072, 2005.
- D. A. Stout and T. J. Webster, “Carbon nanotubes for stem cell control,” Materials Today, vol. 15, no. 7-8, pp. 312–318, 2012.
- S. Samukawa, M. Hori, S. Rauf et al., “The 2012 plasma roadmap,” Journal of Physics D, vol. 45, no. 25, Article ID 253001, 2012.
- D. Mariotti, V. Švrček, and D. G. Kim, “Self-organized nanostructures on atmospheric microplasma exposed surfaces,” Applied Physics Letters, vol. 91, no. 18, Article ID 183111, 2007.
- I. Levchenko, K. Ostrikov, K. Diwan, K. Winkler, and D. Mariotti, “Plasma-driven self-organization of Ni nanodot arrays on Si(100),” Applied Physics Letters, vol. 93, no. 18, Article ID 183102, 2008.
- S. Xu, I. Levchenko, S. Y. Huang, and K. Ostrikov, “Self-organized vertically aligned single-crystal silicon nanostructures with controlled shape and aspect ratio by reactive plasma etching,” Applied Physics Letters, vol. 95, no. 11, Article ID 111505, 2009.
- K. Ostrikov, I. Levchenko, and S. Xu, “Self-organized nanoarrays: plasma-related controls,” Pure and Applied Chemistry, vol. 80, no. 9, pp. 1909–1918, 2008.
- K. Ostrikov, I. Levchenko, U. Cvelbar, M. Sunkara, and M. Mozetic, “From nucleation to nanowires: a single-step process in reactive plasmas,” Nanoscale, vol. 2, no. 10, pp. 2012–2027, 2010.
- G. Arnoult, T. Belmonte, and G. Henrion, “Self-organization of SiO2 nanodots deposited by chemical vapor deposition using an atmospheric pressure remote microplasma,” Applied Physics Letters, vol. 96, no. 10, Article ID 101505, 2010.
- K. Ostrikov, “Colloquium: reactive plasmas as a versatile nanofabrication tool,” Reviews of Modern Physics, vol. 77, no. 2, pp. 489–511, 2005.
- U. Cvelbar, K. Ostrikov, and M. Mozetic, “Reactive oxygen plasma-enabled synthesis of nanostructured CdO: tailoring nanostructures through plasma-surface interactions,” Nanotechnology, vol. 19, no. 40, Article ID 405605, 2008.
- Z. Han, B. Tay, C. Tan, M. Shakerzadeh, and K. Ostrikov, “Electrowetting control of Cassie-to-Wenzel transitions in superhydrophobic carbon nanotube-based nanocomposites,” ACS Nano, vol. 3, no. 10, pp. 3031–3036, 2009.
- A. Michelmore, P. M. Bryant, D. A. Steele, K. Vasilev, J. W. Bradley, and R. D. Short, “Role of positive ions in determining the deposition rate and film chemistry of continuous wave hexamethyl disiloxane plasmas,” Langmuir, vol. 27, no. 19, pp. 11943–11950, 2011.
- S. W. Lee, C. Mattevi, M. Chhowalla, and R. M. Sankaran, “Plasma-assisted reduction of graphene oxide at low temperature and atmospheric pressure for flexible conductor applications,” The Journal of Physical Chemistry Letters, vol. 3, no. 6, pp. 772–777, 2012.
- T. Kato and R. Hatakeyama, “Site- and alignment-controlled growth of graphene nanoribbons from nickel nanobars,” Nature Nanotechnology, vol. 7, no. 10, pp. 651–656, 2012.
- H. G. Yang, C. H. Sun, S. Z. Qiao et al., “Anatase TiO2 single crystals with a large percentage of reactive facets,” Nature, vol. 453, no. 7195, pp. 638–641, 2008.
- H. Watanabe, H. Kondo, M. Hiramatsu et al., “Surface chemical modification of carbon nanowalls for wide-range control of surface wettability,” Plasma Processes and Polymers, vol. 10, no. 7, pp. 582–592, 2013.
- K. Tai, T. J. Houlahan, J. G. Eden, and S. J. Dillon, “Integration of microplasma with transmission electron microscopy: real-time observation of gold sputtering and island formation,” Scientific Reports, vol. 3, article 1325, 2013.
- M. Meyyappan, “A review of plasma enhanced chemical vapour deposition of carbon nanotubes,” Journal of Physics D, vol. 42, no. 21, Article ID 213001, 2009.
- M. Keidar, R. Walk, A. Shashurin et al., “Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy,” British Journal of Cancer, vol. 105, no. 9, pp. 1295–1301, 2011.
- X. Yan, Z. Xiong, F. Zou et al., “Plasma-induced death of HepG2 cancer cells: intracellular effects of reactive species,” Plasma Processes and Polymers, vol. 9, no. 1, pp. 59–66, 2012.
- G. Fridman, G. Friedman, A. Gutsol, A. B. Shekhter, V. N. Vasilets, and A. Fridman, “Applied plasma medicine,” Plasma Processes and Polymers, vol. 5, no. 6, pp. 503–533, 2008.
- M. G. Kong, G. Kroesen, G. Morfill et al., “Plasma medicine: an introductory review,” New Journal of Physics, vol. 11, no. 11, Article ID 115012, 2009.
- J. Heinlin, G. Isbary, W. Stolz et al., “Plasma applications in medicine with a special focus on dermatology,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 1, pp. 1–11, 2011.
- P. Chaudhari, Z. Ye, and Y. Y. Jang, “Roles of reactive oxygen species in the fate of stem cells,” Antioxidants & Redox Signaling, 2012.
- J. E. le Belle, N. M. Orozco, A. A. Paucar et al., “Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner,” Cell Stem Cell, vol. 8, no. 1, pp. 59–71, 2011.
- P. M. Burch and N. H. Heintz, “Redox regulation of cell-cycle re-entry: cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species,” Antioxidants and Redox Signaling, vol. 7, no. 5-6, pp. 741–751, 2005.
- M. Ishaq, M. M. Evans, and K. Ostrikov, “Effect of atmospheric gas plasmas on cancer cell signalling,” International Journal of Cancer, 2013.
- X. Pei, X. Lu, J. Liu et al., “Inactivation of a 25.5 μm Enterococcus faecalis biofilm by a room-temperature, battery-operated, handheld air plasma jet,” Journal of Physics D, vol. 45, no. 16, Article ID 165205, 2012.
- G. Fridman, M. Peddinghaus, M. Balasubramanian et al., “Blood coagulation and living tissue sterilization by floating-electrode dielectric barrier discharge in air,” Plasma Chemistry and Plasma Processing, vol. 26, no. 4, pp. 425–442, 2006.
- O. Lademann, H. Richter, A. Patzelt et al., “Application of a plasma-jet for skin antisepsis: analysis of the thermal action of the plasma by laser scanning microscopy,” Laser Physics Letters, vol. 7, no. 6, pp. 458–462, 2010.
- A. B. Shekhter, V. A. Serezhenkov, T. G. Rudenko, A. V. Pekshev, and A. F. Vanin, “Beneficial effect of gaseous nitric oxide on the healing of skin wounds,” Nitric Oxide—Biology and Chemistry, vol. 12, no. 4, pp. 210–219, 2005.
- M. Vleugels, G. Shama, X. T. Deng, E. Greenacre, T. Brocklehurst, and M. G. Kong, “Atmospheric plasma inactivation of biofilm-forming bacteria for food safety control,” IEEE Transactions on Plasma Science, vol. 33, no. 2, pp. 824–828, 2005.
- S. Deng, R. Ruan, C. K. Mok, G. Huang, X. Lin, and P. Chen, “Inactivation of Escherichia coli on almonds using nonthermal plasma,” Journal of Food Science, vol. 72, no. 2, pp. M62–M66, 2007.
- Y. Xian, X. Lu, J. Liu, S. Wu, D. Liu, and Y. Pan, “Multiple plasma bullet behavior of an atmospheric-pressure plasma plume driven by a pulsed dc voltage,” Plasma Sources Science and Technology, vol. 21, no. 3, Article ID 034013, 2012.
- X. Lu, M. Laroussi, and V. Puech, “On atmospheric-pressure non-equilibrium plasma jets and plasma bullets,” Plasma Sources Science and Technology, vol. 21, no. 3, Article ID 034005, 2012.
- Z. Xiong, S. Zhao, X. Mao et al., “Selective neuronal differentiation of neural stem cells induced by nanosecond microplasma agitation,” Stem Cell Research, 2013.
- P. Attri, B. Arora, and E. H. Choi, “Utility of plasma: a new road from physics to chemistry,” RSC Advances, vol. 3, no. 31, pp. 12540–12567, 2013.
- J. Zheng, R. Yang, L. Xie, J. Qu, Y. Liu, and X. Li, “Plasma-assisted approaches in inorganic nanostructure fabrication,” Advanced Materials, vol. 22, no. 13, pp. 1451–1473, 2010.
- M. J. Dalby, N. Gadegaard, and C. D. W. Wilkinson, “The response of fibroblasts to hexagonal nanotopography fabricated by electron beam lithography,” Journal of Biomedical Materials Research A, vol. 84, no. 4, pp. 973–979, 2008.
- S. Simovic, D. Losic, and K. Vasilev, “Controlled drug release from porous materials by plasma polymer deposition,” Chemical Communications, vol. 46, no. 8, pp. 1317–1319, 2010.
- R. J. Anthony, K. Y. Cheng, Z. C. Holman, R. J. Holmes, and U. R. Kortshagen, “An all-gas-phase approach for the fabrication of silicon nanocrystal light-emitting devices,” Nano Letters, vol. 12, no. 6, pp. 2822–2825, 2012.
- S. Kumar, I. Levchenko, K. Ostrikov, and J. A. McLaughlin, “Plasma-enabled, catalyst-free growth of carbon nanotubes on mechanically-written Si features with arbitrary shape,” Carbon, vol. 50, no. 1, pp. 325–329, 2012.
- X. Z. Huang, X. X. Zhong, Y. Lu et al., “Plasmonic Ag nanoparticles via environment-benign atmospheric microplasma electrochemistry,” Nanotechnology, vol. 24, no. 9, Article ID 095604, 2013.
- H. R. Maurer and H. Kersten, “On the heating of nano- and microparticles in process plasmas,” Journal of Physics D, vol. 44, no. 17, Article ID 174029, 2011.
- M. Shiratani, K. Koga, S. Ando et al., “Single step method to deposit Si quantum dot films using H2 + SiH4 VHF discharges and electron mobility in a Si quantum dot solar cell,” Surface and Coatings Technology, vol. 201, no. 9–11, pp. 5468–5471, 2007.
- S. Kumar, I. Levchenko, M. Keidar, and K. Ostrikov, “Plasma-enabled growth of separated, vertically aligned copper-capped carbon nanocones on silicon,” Applied Physics Letters, vol. 97, no. 15, Article ID 151503, 2010.
- S. Kumar and K. Ostrikov, “Unidirectional arrays of vertically standing graphenes in reactive plasmas,” Nanoscale, vol. 3, no. 10, pp. 4296–4300, 2011.
- S. Chattopadhyay, Y. F. Huang, Y. J. Jen, A. Ganguly, K. H. Chen, and L. C. Chen, “Anti-reflecting and photonic nanostructures,” Materials Science and Engineering R, vol. 69, no. 1–3, pp. 1–35, 2010.
- C. Cha, S. R. Shin, N. Annabi, M. R. Dokmeci, and A. Khademhosseini, “Carbon-based nanomaterials: multifunctional materials for biomedical engineering,” ACS Nano, vol. 7, no. 4, pp. 2891–2897, 2013.